Drug intelligence / Profile preview

Propyduo

Development stage: Preclinical
Modality: Hydrogel Systems → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

Propyduo is a new moisturizer undergoing clinical trials for its effects on individuals with atopic dermatitis, commonly known as eczema. The product is designed to strengthen the skin barrier, which is the outermost layer of the skin responsible for protection against irritants and infections. The study aims to evaluate its effectiveness over four weeks compared to no treatment and other reference products like Propyless and Canoderm, by measuring improvements in skin health, moisture levels, and reactions.

Brand names: Propyduo

Beyond the preview

Go deeper on Propyduo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propyduo.

Explore the full profile